The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults.
Antai-Otong
Deborah
D
deborah.antai-otong@med.va.gov
D000081:Acetamides / Q000627:therapeutic use; D000208:Acute Disease; D053961:Azabicyclo Compounds; D001569:Benzodiazepines / Q000009:adverse effects; D015984:Causality; D011307:Drug Prescriptions; D018755:GABA Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D009730:Nursing Assessment; D018579:Patient Selection; D010879:Piperazines / Q000627:therapeutic use; D015995:Prevalence; D017009:Professional Autonomy; D011568:Psychiatric Nursing / Q000458:organization & administration*; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D000077334:Zolpidem
D000081:Acetamides; D053961:Azabicyclo Compounds; D018755:GABA Agonists; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011725:Pyridines; D011743:Pyrimidines; C515050:zopiclone; D001569:Benzodiazepines; D000077334:Zolpidem; C085665:zaleplon